Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc. /DE/

DNTH Clue Score31
United States Fiscal year ends December CIK 0001690585
82.37
-0.07%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
82.37 on 9 Oct 2026
116 74 33 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $34.42 14 Oct 2025 $35.55 15 Oct 2025 $36.20 16 Oct 2025 $36.00 17 Oct 2025 $35.65 20 Oct 2025 $36.00 21 Oct 2025 $35.03 22 Oct 2025 $33.45 23 Oct 2025 $33.27 24 Oct 2025 $32.92 27 Oct 2025 $33.52 28 Oct 2025 $33.67 29 Oct 2025 $33.82 30 Oct 2025 $33.74 31 Oct 2025 $34.98 3 Nov 2025 $34.03 4 Nov 2025 $33.20 5 Nov 2025 $33.73 6 Nov 2025 $36.43 7 Nov 2025 $36.28 10 Nov 2025 $36.61 11 Nov 2025 $36.10 12 Nov 2025 $38.72 13 Nov 2025 $35.50 14 Nov 2025 $40.85 17 Nov 2025 $41.35 18 Nov 2025 $40.82 19 Nov 2025 $40.79 20 Nov 2025 $40.39 21 Nov 2025 $41.45 24 Nov 2025 $43.68 25 Nov 2025 $44.09 26 Nov 2025 $44.03 28 Nov 2025 $43.98 1 Dec 2025 $43.20 2 Dec 2025 $42.28 3 Dec 2025 $43.97 4 Dec 2025 $44.71 5 Dec 2025 $44.26 8 Dec 2025 $43.60 9 Dec 2025 $43.58 10 Dec 2025 $43.58 11 Dec 2025 $41.63 12 Dec 2025 $42.13 15 Dec 2025 $41.92 16 Dec 2025 $41.40 17 Dec 2025 $41.43 18 Dec 2025 $41.75 19 Dec 2025 $42.44 22 Dec 2025 $43.77 23 Dec 2025 $42.61 24 Dec 2025 $43.15 26 Dec 2025 $41.83 29 Dec 2025 $41.62 30 Dec 2025 $40.96 31 Dec 2025 $41.21 2 Jan 2026 $39.68 5 Jan 2026 $36.89 6 Jan 2026 $36.20 7 Jan 2026 $38.09 8 Jan 2026 $38.12 9 Jan 2026 $38.19 12 Jan 2026 $39.12 13 Jan 2026 $44.86 14 Jan 2026 $46.29 15 Jan 2026 $44.00 16 Jan 2026 $44.10 20 Jan 2026 $46.60 21 Jan 2026 $48.03 22 Jan 2026 $52.76 23 Jan 2026 $52.33 26 Jan 2026 $51.17 27 Jan 2026 $50.31 28 Jan 2026 $50.50 29 Jan 2026 $53.36 30 Jan 2026 $53.39 2 Feb 2026 $53.18 3 Feb 2026 $52.46 4 Feb 2026 $48.13 5 Feb 2026 $46.58 6 Feb 2026 $50.75 9 Feb 2026 $52.71 10 Feb 2026 $50.82 11 Feb 2026 $49.92 12 Feb 2026 $47.48 13 Feb 2026 $47.40 17 Feb 2026 $49.21 18 Feb 2026 $47.47 19 Feb 2026 $49.72 20 Feb 2026 $49.56 23 Feb 2026 $52.68 24 Feb 2026 $52.86 25 Feb 2026 $51.87 26 Feb 2026 $53.11 27 Feb 2026 $55.19 2 Mar 2026 $55.26 3 Mar 2026 $55.39 4 Mar 2026 $62.03 5 Mar 2026 $61.43 6 Mar 2026 $65.20 9 Mar 2026 $79.23 10 Mar 2026 $86.92 11 Mar 2026 $85.84 12 Mar 2026 $80.32 13 Mar 2026 $77.86 16 Mar 2026 $78.00 17 Mar 2026 $78.90 18 Mar 2026 $78.86 19 Mar 2026 $80.00 20 Mar 2026 $77.76 23 Mar 2026 $79.32 24 Mar 2026 $78.55 25 Mar 2026 $79.61 26 Mar 2026 $82.45 27 Mar 2026 $81.13 30 Mar 2026 $79.45 31 Mar 2026 $83.92 1 Apr 2026 $84.56 2 Apr 2026 $86.00 6 Apr 2026 $85.50 7 Apr 2026 $86.20 8 Apr 2026 $87.48 9 Apr 2026 $91.66 10 Apr 2026 $89.77 13 Apr 2026 $90.00 14 Apr 2026 $94.91 15 Apr 2026 $95.76 16 Apr 2026 $92.90 17 Apr 2026 $93.26 20 Apr 2026 $91.92 21 Apr 2026 $90.15 22 Apr 2026 $91.29 23 Apr 2026 $89.82 24 Apr 2026 $87.39 27 Apr 2026 $87.16 28 Apr 2026 $83.67 29 Apr 2026 $83.50 30 Apr 2026 $87.80 1 May 2026 $87.42 4 May 2026 $89.34 5 May 2026 $90.24 6 May 2026 $90.42 7 May 2026 $85.47 8 May 2026 $86.71 11 May 2026 $87.12 12 May 2026 $86.15 13 May 2026 $85.74 14 May 2026 $85.34 15 May 2026 $86.16 18 May 2026 $83.60 19 May 2026 $85.67 20 May 2026 $88.72 21 May 2026 $89.63 22 May 2026 $86.48 26 May 2026 $86.82 27 May 2026 $86.67 28 May 2026 $90.86 29 May 2026 $93.01 1 Jun 2026 $89.45 2 Jun 2026 $81.57 3 Jun 2026 $84.97 4 Jun 2026 $84.13 5 Jun 2026 $80.51 8 Jun 2026 $81.22 9 Jun 2026 $84.57 10 Jun 2026 $76.42 11 Jun 2026 $76.45 12 Jun 2026 $82.07 15 Jun 2026 $82.51 16 Jun 2026 $78.88 17 Jun 2026 $81.89 18 Jun 2026 $82.49 22 Jun 2026 $87.37 23 Jun 2026 $87.53 24 Jun 2026 $90.80 25 Jun 2026 $91.57 26 Jun 2026 $95.35 29 Jun 2026 $95.68 30 Jun 2026 $97.48 1 Jul 2026 $90.21 2 Jul 2026 $94.34 6 Jul 2026 $93.34 7 Jul 2026 $95.76 8 Jul 2026 $98.07 9 Jul 2026 $100.03 10 Jul 2026 $97.60 13 Jul 2026 $98.64 14 Jul 2026 $101.28 15 Jul 2026 $99.91 16 Jul 2026 $95.35 17 Jul 2026 $105.60 20 Jul 2026 $101.00 21 Jul 2026 $105.72 22 Jul 2026 $102.76 23 Jul 2026 $104.79 24 Jul 2026 $103.87 27 Jul 2026 $104.49 28 Jul 2026 $101.61 29 Jul 2026 $104.09 30 Jul 2026 $112.64 31 Jul 2026 $106.92 3 Aug 2026 $106.02 4 Aug 2026 $110.40 5 Aug 2026 $112.50 6 Aug 2026 $109.92 7 Aug 2026 $108.92 10 Aug 2026 $111.80 11 Aug 2026 $108.49 12 Aug 2026 $112.41 13 Aug 2026 $109.60 14 Aug 2026 $115.96 17 Aug 2026 $114.86 18 Aug 2026 $115.54 19 Aug 2026 $113.70 20 Aug 2026 $109.51 21 Aug 2026 $111.10 24 Aug 2026 $110.07 25 Aug 2026 $112.11 26 Aug 2026 $110.76 27 Aug 2026 $111.54 28 Aug 2026 $105.84 31 Aug 2026 $105.61 1 Sep 2026 $106.62 2 Sep 2026 $106.24 3 Sep 2026 $107.85 4 Sep 2026 $108.10 8 Sep 2026 $109.13 9 Sep 2026 $107.04 10 Sep 2026 $103.28 11 Sep 2026 $106.20 14 Sep 2026 $107.69 15 Sep 2026 $104.77 16 Sep 2026 $102.49 17 Sep 2026 $101.12 18 Sep 2026 $96.81 21 Sep 2026 $96.47 22 Sep 2026 $98.35 23 Sep 2026 $93.44 24 Sep 2026 $90.71 25 Sep 2026 $88.55 28 Sep 2026 $87.83 29 Sep 2026 $87.16 30 Sep 2026 $88.05 1 Oct 2026 $88.32 2 Oct 2026 $88.21 5 Oct 2026 $88.04 6 Oct 2026 $85.40 7 Oct 2026 $84.88 8 Oct 2026 $82.43 9 Oct 2026 $82.37 Randhawa Simrat EVP, Head of R&D Sold on a plan $3.22M 13 Nov 2025 · at $36.81 · 95.6% of stake Randhawa Simrat EVP, Head of R&D Sold on a plan $4.16M 14 Nov 2025 · at $38.14 · 96.5% of stake Savitz Ryan CFO & CBO Sold on a plan $903.60K 4 Dec 2025 · at $45.18 · 100% of stake Randhawa Simrat EVP, Head of R&D Sold on a plan $2.76M 12 Mar 2026 · at $81.48 · 100% of stake CARR EDWARD CHIEF ACCOUNTING OFFICER Sold on a plan $3.56M 12 Mar 2026 · at $81.49 · 100% of stake Garcia Marino CEO AND PRESIDENT Sold on a plan $10.02M 12 Mar 2026 · at $81.49 · 100% of stake Soteropoulos Paula Director Sold on a plan $2.15M 24 Mar 2026 · at $78.05 · 100% of stake Soteropoulos Paula Director Sold on a plan $47.99K 31 Mar 2026 · at $80.11 · 100% of stake Savitz Ryan EVP, CFO & CBO Sold on a plan $9.49M 31 Mar 2026 · at $83.00 · 100% of stake Savitz Ryan EVP, CFO & CBO Sold on a plan $738.84K 9 Apr 2026 · at $89.84 · 100% of stake Soteropoulos Paula Director Sold on a plan $51.20K 8 May 2026 · at $85.47 · 100% of stake Randhawa Simrat EVP, Head of R&D Sold on a plan $2.40M 1 Jun 2026 · at $90.62 · 86.9% of stake Veness Adam M SVP, General Counsel and Sec. Sold on a plan $2.42M 17 Jun 2026 · at $80.80 · 100% of stake Savitz Ryan EVP, CFO & CBO Sold on a plan $3.16M 9 Jul 2026 · at $101.03 · 100% of stake Veness Adam M SVP, General Counsel and Sec. Sold on a plan $424.32K 7 Aug 2026 · at $110.70 · 100% of stake Garcia Marino CEO AND PRESIDENT Sold on a plan $17.95M 7 Aug 2026 · at $108.11 · 71.8% of stake Read Simon Director Sold on a plan $304.23K 10 Aug 2026 · at $109.55 · 100% of stake McGeorge Anne Director Sold on a plan $844.82K 10 Aug 2026 · at $109.01 · 100% of stake Veness Adam M SVP, General Counsel and Sec. Sold on a plan $1.78M 10 Aug 2026 · at $110.38 · 100% of stake Read Simon Director Sold on a plan $326.55K 19 Aug 2026 · at $117.55 · 100% of stake Randhawa Simrat EVP, Head of R&D Sold on a plan $2.46M 1 Sep 2026 · at $106.41 · 85.3% of stake CARR EDWARD CHIEF ACCOUNTING OFFICER Sold on a plan $2.03M 17 Sep 2026 · at $101.38 · 100% of stake
0 buys0 sales at will22 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$2.04M
Net income
$162.34M
Free cash flow
$129.06M
Operating margin
-8,739.3%
Net margin
-7,973.3%
Return on equity
-32.9%
Return on capital
-28.5%
Revenue growth, 1 yr
-67.4%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -75M FY20 Fiscal year 2020 Revenue $0.00 Net income $74.94M Margin n/a 0K -71M FY21 Fiscal year 2021 Revenue $0.00 Net income $71.14M Margin n/a 0K -28M FY22 Fiscal year 2022 Revenue $0.00 Net income $28.48M Margin n/a 3M -44M FY23 Fiscal year 2023 Revenue $2.83M Net income $43.56M Margin -1,541.2% 6M -85M FY24 Fiscal year 2024 Revenue $6.24M Net income $84.97M Margin -1,362.8% · growth +120.6% 2M -162M FY25 Fiscal year 2025 Revenue $2.04M Net income $162.34M Margin -7,973.3% · growth -67.3%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
17 Sep 2026 CARR EDWARD
CHIEF ACCOUNTING OFFICER
Sold on a plan $2.03M 100%
1 Sep 2026 Randhawa Simrat
EVP, Head of R&D
Sold on a plan $2.46M 85.3%
19 Aug 2026 Read Simon
Director
Sold on a plan $326.55K 100%
10 Aug 2026 Veness Adam M
SVP, General Counsel and Sec.
Sold on a plan $1.78M 100%
10 Aug 2026 McGeorge Anne
Director
Sold on a plan $844.82K 100%
10 Aug 2026 Read Simon
Director
Sold on a plan $304.23K 100%